Spruce Biosciences, Inc. Basic Shares Outstanding (Weighted Average)
Spruce Biosciences, Inc. (SPRB) reported Basic Shares Outstanding (Weighted Average) of 2.43 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- Spruce Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 2.43M shares, a 311.25% increase year-over-year.
- Spruce Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 1.37M shares, a 134.09% increase year-over-year.
- Spruce Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 1.30M shares, a 134.59% increase year-over-year.
- Spruce Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 563.07K shares, a 2.26% increase year-over-year.
- Spruce Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 766.60K shares, a 39.34% increase from fiscal 2024.
- Spruce Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 550.15K shares, a 98.57% decline from fiscal 2023.
- Spruce Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 38.51M shares, a 63.68% increase from fiscal 2022.
- Spruce Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 23.53M shares, a 0.71% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.43M shares 10-Q · filed 2026-08-12 | 1.90M shares 10-Q · filed 2026-08-12 | 1.70M shares derived: average of 3 quarters · filed 2026-08-12 | 1.42M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | 1.37M shares 10-Q · filed 2026-05-13 | 1.33M shares derived: average of 2 quarters · filed 2026-05-13 | 1.08M shares derived: average of 3 quarters · filed 2026-05-13 | 956.03K shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | 1.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 930.45K shares derived: average of 2 quarters · filed 2026-03-09 | 817.35K shares derived: average of 3 quarters · filed 2026-08-12 | 766.60K shares 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | 563.07K shares 10-Q · filed 2025-11-10 | 577.10K shares derived: average of 2 quarters · filed 2026-08-12 | 589.52K shares 10-Q · filed 2025-11-10 | 573.40K shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | 591.14K shares 10-Q · filed 2026-08-12 | 588.65K shares 10-Q · filed 2026-08-12 | 576.84K shares derived: average of 3 quarters · filed 2026-08-12 | 570.29K shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | 586.14K shares 10-Q · filed 2026-05-13 | 43.94M shares 10-Q · filed 2025-05-06 | 569.69K shares derived: average of 2 quarters · filed 2026-05-13 | 563.34K shares derived: average of 3 quarters · filed 2026-05-13 | 559.70K shares derived: average of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | 553.24K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 551.94K shares derived: average of 2 quarters · filed 2026-03-09 | 550.89K shares derived: average of 3 quarters · filed 2026-03-09 | 550.15K shares 10-K · filed 2026-03-09 | 41.26M shares 10-K · filed 2025-04-15 | |||
| 2024-09-30 | 550.64K shares 10-Q · filed 2025-11-10 | 41.30M shares 10-Q · filed 2024-11-12 | 549.72K shares derived: average of 2 quarters · filed 2025-11-10 | 549.12K shares 10-Q · filed 2025-11-10 | 41.19M shares 10-Q · filed 2024-11-12 | 20.75M shares derived: average of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | 548.79K shares 10-Q · filed 2025-08-14 | 41.16M shares 10-Q · filed 2024-08-12 | 548.34K shares 10-Q · filed 2025-08-14 | 41.13M shares 10-Q · filed 2024-08-12 | 27.48M shares derived: average of 3 quarters · filed 2025-08-14 | 30.79M shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 41.10M shares 10-Q · filed 2025-05-06 | 40.94M shares derived: average of 2 quarters · filed 2025-05-06 | 40.86M shares derived: average of 3 quarters · filed 2025-05-06 | 40.79M shares derived: average of 4 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | 40.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | 40.75M shares derived: average of 2 quarters · filed 2025-04-15 | 40.68M shares derived: average of 3 quarters · filed 2025-04-15 | 38.51M shares 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | 40.71M shares 10-Q · filed 2024-11-12 | 40.63M shares derived: average of 2 quarters · filed 2024-11-12 | 37.75M shares 10-Q · filed 2024-11-12 | 34.18M shares derived: average of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | 40.55M shares 10-Q · filed 2024-08-12 | 36.25M shares 10-Q · filed 2024-08-12 | 32.00M shares derived: average of 3 quarters · filed 2024-08-12 | 29.89M shares derived: average of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | 31.90M shares 10-Q · filed 2024-05-13 | 27.73M shares derived: average of 2 quarters · filed 2024-05-13 | 26.34M shares derived: average of 3 quarters · filed 2024-05-13 | 25.63M shares derived: average of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | 23.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | 23.56M shares derived: average of 2 quarters · filed 2024-03-18 | 23.54M shares derived: average of 3 quarters · filed 2024-03-18 | 23.53M shares 10-K · filed 2024-03-18 | ||||
| 2022-09-30 | 23.56M shares 10-Q · filed 2023-11-13 | 23.53M shares derived: average of 2 quarters · filed 2023-11-13 | 23.52M shares 10-Q · filed 2023-11-13 | 23.50M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | 23.49M shares 10-Q · filed 2023-08-14 | 23.49M shares 10-Q · filed 2023-08-14 | 23.48M shares derived: average of 3 quarters · filed 2023-08-14 | 23.45M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 23.49M shares 10-Q · filed 2023-05-15 | 23.47M shares derived: average of 2 quarters · filed 2023-05-15 | 23.44M shares derived: average of 3 quarters · filed 2023-05-15 | |||||
| 2021-12-31 | 23.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 23.41M shares derived: average of 2 quarters · filed 2023-03-16 | 23.36M shares 10-K · filed 2023-03-16 | |||||
| 2021-09-30 | 23.37M shares 10-Q · filed 2022-11-10 | 23.33M shares 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |